Technology is opening new possibilities for how multiple sclerosis is monitored, treated and managed.
In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Ellen Mowry of Johns Hopkins University and Prof. Letizia Leocani of Vita-Salute San Raffaele University about how innovative medical technologies could transform MS research and clinical care.
Together, they explore:
How artifical intelligence, wearable devices and digital biomarkers could help monitor MS progression
The potential to capture fatigue, cognition, pain, mood, sleep and other symptoms between clinical visits
How passive monitoring could provide a more complete picture of everyday life with MS
The growing role of virtual rehabilitation, digital therapies and other technologies in bringing care into people's homes
Why digital biomarkers require rigorous research and validation before being used in clinical trials
From earlier detection of disability progression to more accessible rehabilitation and personalised symptom management, this episode examines both the opportunities and challenges of using technology to improve MS care.
---
This podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases, Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.
Podden och tillhörande omslagsbild på den här sidan tillhör
The European Committee for Treatment and Research in Multiple Sclerosis. Innehållet i podden är skapat av The European Committee for Treatment and Research in Multiple Sclerosis och inte av,
eller tillsammans med, Poddtoppen.